Table 3.
AVF patency in each underlying disease | aspirin (%) | p - value | dipyridamol (%) | p-value | control (%) |
---|---|---|---|---|---|
DM | 14/20 (70%) | 0.9531 | 28/35 (80%) | 0.5065 | 29/41 (70.7%) |
HTN | 21/33 (63.6%) | 0.5911 | 30/38 (78.9%) | 0.6486 | 31/43 (72.1%) |
HTN+DM | 29/45 (64.4%) | 0.7958 | 22/36 (61.1%) | 0.8386 | 17/29 (58.6%) |